0 NASDAQ Companies - April 2, 2025Kestra Medical Technologies, Ltd. to Report Third Quarter Fiscal 2025 Financial Results on April 14KIRKLAND, Wash., April 02, 2025 (GLOBE NEWSWIRE) — Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital […]Read More
0 NASDAQ Companies - April 2, 2025BBSI Announces Appointment of Thomas McGinn as Senior Vice President of InsuranceVANCOUVER, Wash., April 02, 2025 (GLOBE NEWSWIRE) — Barrett Business Services, Inc. (BBSI) (NASDAQ: BBSI), a leading provider of business […]Read More
0 NASDAQ Companies - April 2, 2025Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)FOSTER CITY, Calif., April 02, 2025 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage […]Read More
0 NASDAQ Companies - April 2, 2025eXoZymes Provides Fourth Quarter and Full Year 2024 UpdateManagement to Host Conference Call Today at 4:30PM Eastern Monrovia, CA, April 02, 2025 (GLOBE NEWSWIRE) — Today, eXoZymes Inc. […]Read More
0 NASDAQ Companies - April 2, 2025Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business UpdateBERKELEY HEIGHTS, N.J., April 02, 2025 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), […]Read More
0 NASDAQ Companies - April 2, 2025GigaCloud Technology Inc Increases Share Repurchase Program by $16 MillionEL MONTE, Calif., April 02, 2025 (GLOBE NEWSWIRE) — GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer […]Read More
0 NASDAQ Companies - April 2, 2025GRI Bio Announces Closing of $5.0 Million Public OfferingLA JOLLA, CA, April 02, 2025 (GLOBE NEWSWIRE) — GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a […]Read More
0 NASDAQ Companies - April 2, 2025Compass Therapeutics to Participate in the Stifel 2025 Virtual Targeted Oncology ForumBOSTON, April 02, 2025 (GLOBE NEWSWIRE) — Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based […]Read More
0 NYSE Companies - April 2, 2025Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) — Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial […]Read More
0 NYSE Companies - April 2, 2025Alpine Income Property Trust Announces First Quarter 2025 Transaction Activity and Balance Sheet UpdateWINTER PARK, Fla., April 02, 2025 (GLOBE NEWSWIRE) — Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) today announced […]Read More